Skip to content

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
AbbVie logo
AbbVieABBV
0.8×0.0×
Establishment Labs logo
Establishment LabsESTA
-0.4×
Bausch Health Companies logo
Bausch Health CompaniesBHC
1.3×0.0×

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Based on the most recent quarter.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s current ratio?
AirSculpt Technologies, Inc. (AIRS) reported current ratio of 0.7× in Q1 2026.
How has AirSculpt Technologies, Inc.'s current ratio changed year-over-year?
AirSculpt Technologies, Inc.'s current ratio increased by 31.2% year-over-year, from 0.6× to 0.7×.
What is the long-term trend for AirSculpt Technologies, Inc.'s current ratio?
Over 5 years (2020 to 2025), AirSculpt Technologies, Inc.'s current ratio has grown at a -14.6% compound annual growth rate (CAGR), from 1.2× to 0.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.